Overview of Multiple Myeloma
Treatment of Recurrent Multiple Myeloma
Newsletter Signup | Join Community | Cancer Types
Understand the risks-benefits of Revlimid, Ninlaro & Velcade maintenance therapy for Multiple Myeloma; 2019 ASH update.
Darzalex is effective myeloma treatment in several settings - most recently for transplant ineligible patients.
2019 ASH update: ASCT treatment of multiple myeloma improves outcomes even in individuals older than 70.;
Blenrep is a precision medicine that targets the BCMA in myeloma - Now FDA approved but concerns of ocular side effects.
ASCO 2020 update on CAR-T therapy in multiple myeloma and other targeted therapies. CAR T continues to look promising.
Sarclisa precision cancer medicine improves survival in advanced Multiple Myeloma - leads to FDA approval
Initial clinical results for REGN 5458 Bispecific Antibody appear promising for treatment of advanced myeloma.
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed.…
UK doctors identify a new target for treating Multiple Myeloma: http://www.imperial.ac…